ArticleEClinicalMedicine2023

Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis.

Irene Caruso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.